Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
May 15, 2017
The article discusses how new technologies like Face2Gene are revolutionizing the diagnosis of rare genetic disorders. Face2Gene uses advanced AI algorithms to analyze facial features and identify potential genetic syndromes, significantly aiding medical professionals in expediting rare genetic diagnoses. The app enhances the accuracy and speed of diagnostic processes, providing invaluable support to geneticists and clinicians. By leveraging machine learning, Face2Gene can recognize patterns and anomalies that are crucial for identifying rare genetic conditions. This technological advancement represents a significant step forward in personalized medicine, offering hope for more accurate and earlier diagnoses of rare genetic disorders.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…